Pfizer Inc.

NYSE:PFE   10:03:46 AM EDT
43.85
-0.09 (-0.20%)
Strategic Combinations, Earnings Announcements

HLS Therapeutics Announces Promotional Agreement With Pfizer For Vascepa

Published: 08/16/2021 10:41 GMT
Pfizer Inc. (PFE) - Hls Therapeutics Announces Promotional Agreement With Pfizer for Vascepa® in Canada.
Hls Therapeutics Inc - Hls Will Continue to Focus Primarily on Specialists While Pfizer Will Focus Primarily on Primary Care Physicians.
Hls Therapeutics - Under Agreement, Pfizer Will Deploy a Team Across Canada to Support Education About Vascepa With Primary Care Physician Groups.
Hls Therapeutics - Hls Will Retain Responsibility Over Vascepa's Commercialization and Will Record All Revenue Related to Vascepa Sales in Canada.
Revenue is expected to be $22.83 Billion
Adjusted EPS is expected to be $1.09

Next Quarter Revenue Guidance is expected to be $24.44 Billion
Next Quarter EPS Guidance is expected to be $1.04

More details on our Analysts Page.